Gene · 5352
Papers1,610
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 1,610
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Role of P4HA1 in Multiple Cancer Types and its Potential as a Target in Renal Cell Carcinoma. | Front Genet | 2022 | 35812752 | PubTator, text mining | PubMed |
| Emergence of Resistance to MTI-101 Selects for a MET Genotype and Phenotype in EGFR Driven PC-9 and PTEN Deleted H446 Lung Cancer Cell Lines. | Cancers (Basel) | 2022 | 35804837 | PubTator, text mining | PubMed |
| Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1. | Nat Chem Biol | 2022 | 35788181 | PubTator, text mining | PubMed |
| N7-Methylguanosine Regulatory Genes Profoundly Affect the Prognosis, Progression, and Antitumor Immune Response of Hepatocellular Carcinoma. | Front Surg | 2022 | 35784919 | PubTator, text mining | PubMed |
| 3'UTR-Seq analysis of chicken abdominal adipose tissue reveals widespread intron retention in 3'UTR and provides insight into molecular basis of feed efficiency. | PLoS One | 2022 | 35776773 | PubTator, text mining | PubMed |
| Extracellular Matrix Stiffness in Lung Health and Disease. | Compr Physiol | 2022 | 35766837 | PubTator, text mining | PubMed |
| Patient-reported outcomes in a Chinese cohort of osteogenesis imperfecta unveil psycho-physical stratifications associated with clinical manifestations. | Orphanet J Rare Dis | 2022 | 35765008 | PubTator, text mining | PubMed |
| An oncogenic JMJD6-DGAT1 axis tunes the epigenetic regulation of lipid droplet formation in clear cell renal cell carcinoma. | Mol Cell | 2022 | 35764091 | PubTator, text mining | PubMed |
| An N-glycoproteomic site-mapping analysis reveals glycoprotein alterations in esophageal squamous cell carcinoma. | J Transl Med | 2022 | 35752862 | PubTator, text mining | PubMed |
| Comprehensive Proteomic Characterization of Articular Cartilage from Femoral Head Necrosis Patients. | Front Biosci (Landmark Ed) | 2022 | 35748257 | PubTator, text mining | PubMed |
| Coupled fibromodulin and SOX2 signaling as a critical regulator of metastatic outgrowth in melanoma. | Cell Mol Life Sci | 2022 | 35737114 | PubTator, text mining | PubMed |
| Cellular Senescence-Related Genes: Predicting Prognosis in Gastric Cancer. | Front Genet | 2022 | 35719376 | PubTator, text mining | PubMed |
| The Underlying Molecular Basis and Mechanisms of Venous Thrombosis in Patients with Osteomyelitis: A Data-Driven Analysis. | Genet Res (Camb) | 2022 | 35711689 | PubTator, text mining | PubMed |
| Molecular mechanisms of cystic fibrosis - how mutations lead to misfunction and guide therapy. | Biosci Rep | 2022 | 35707985 | PubTator, text mining | PubMed |
| An Unusual Diagnosis of Sporadic Type III Osteogenesis Imperfecta in the First Day of Life. | Case Rep Pediatr | 2022 | 35706981 | PubTator, text mining | PubMed |
| The pleiotropic roles of adipocyte secretome in remodeling breast cancer. | J Exp Clin Cancer Res | 2022 | 35701840 | PubTator, text mining | PubMed |
| Progesterone and its receptor signaling in cervical remodeling: Mechanisms of physiological actions and therapeutic implications. | J Steroid Biochem Mol Biol | 2022 | 35690241 | PubTator, text mining | PubMed |
| Tissue catabolism and donor-specific dexamethasone response in a human osteochondral model of post-traumatic osteoarthritis. | Arthritis Res Ther | 2022 | 35689293 | PubTator, text mining | PubMed |
| PLOD2 Is a Prognostic Marker in Glioblastoma That Modulates the Immune Microenvironment and Tumor Progression. | Int J Mol Sci | 2022 | 35682709 | PubTator, text mining | PubMed |
| Hypoxia Selectively Increases a SMAD3 Signaling Axis to Promote Cancer Cell Invasion. | Cancers (Basel) | 2022 | 35681731 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5352/papers?page=20